Structure Therapeutics
Structure Therapeutics develops orally available, small molecule medicines, focusing on chronic diseases such as type 2 diabetes, obesity, and pulmonary diseases, with operations in the US and China.
Services
Structure Therapeutics develops orally available, small molecule medicines designed to transform patient lives globally. The company focuses on treatments for chronic diseases with unmet global needs, including type 2 diabetes, obesity, and pulmonary diseases. Their platform integrates visualization of molecular interactions, computational chemistry, and data integration, enabling the development of oral small molecule drugs that deliver biologic-like activity and specificity.
Drug Development Technologies
Structure Therapeutics utilizes advanced computing and structure-based technologies for drug development. Their approach leverages visualization of molecular interactions and computational chemistry, alongside data integration, to create effective treatments. This enables the company to pioneer solutions tailored to chronic diseases with substantial global demands.
Target Chronic Diseases
Structure Therapeutics targets chronic diseases that have significant unmet global needs. Their primary focus areas include type 2 diabetes, obesity, and pulmonary diseases. By advancing multiple pipeline programs, the company aims to offer innovative oral small molecule medicines that can improve patient outcomes and quality of life.
Global Presence
Structure Therapeutics operates from offices in the United States and China, leveraging talent and resources from the top two pharmaceutical markets. This international presence allows the company to integrate diverse perspectives and expertise, boosting their capabilities in developing advanced treatment solutions for chronic diseases.